Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma (Q59616741)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

17 January 2020

main subject

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Porrata LF

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Inwards DJ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ansell SM

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Micallef IN

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Johnston PB

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Gastineau DA

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Markovic SN

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

865-871

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

Mantle-cell lymphoma: a population-based clinical study.

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Mantle cell lymphoma: a retrospective study of 121 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Autologous hematopoietic stem cell transplantation for mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the Eur

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: the prognostic value of beta2-microglobulin and the tumor score

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Autologous stem cell transplantation in patients with mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Prognostic analysis of early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy with an autologous hematopoietic progenitor cell transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Evaluating the yield of medical tests

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Treatment of murine leukaemia with x-rays and homologous bone marrow. II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

B cell-dependent TCR diversification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705342

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705342

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532015%20AND%20SRC:MED&resulttype=core&format=json